Related references
Note: Only part of the references are listed.Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy
Keunok Jung et al.
MOLECULAR CANCER (2022)
Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
Guiqin Xie et al.
BIOLOGY-BASEL (2022)
Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy
Keunok Jung et al.
FRONTIERS IN IMMUNOLOGY (2022)
Preparation of a novel EGFR specific immunotoxin and its efficacy of anti-colorectal cancer in vitro and in vivo
Shuifa Wu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity
Jung-Eun Kim et al.
FRONTIERS IN IMMUNOLOGY (2021)
A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells
Keunok Jung et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Critical Issues in the Development of Immunotoxins for Anticancer Therapy
Ji-Sun Kim et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity
Zeliang Zheng et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Immunotoxin SS1P is rapidly removed by proximal tubule cells of kidney, whose damage contributes to albumin loss in urine
Xui-Fen Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant-driven tumor growth
Seung-Min Shin et al.
SCIENCE ADVANCES (2020)
Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation
Ronit Mazor et al.
FRONTIERS IN IMMUNOLOGY (2020)
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Joao M. Fernandes Neto et al.
NATURE COMMUNICATIONS (2020)
Intein-mediated cytoplasmic reconstitution of a split toxin enables selective cell ablation in mixed populations and tumor xenografts
Vedud Purde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Targeting Receptors on Cancer Cells with Protein Toxins
Antonella Antignani et al.
BIOMOLECULES (2020)
Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer
Alexandra Fischer et al.
TOXINS (2020)
Analyzing expression and phosphorylation of the EGF receptor in HNSCC
Malte Kriegs et al.
SCIENTIFIC REPORTS (2019)
Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer
Ye-Jin Kim et al.
CANCER LETTERS (2019)
Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability
Du-San Baek et al.
MOLECULAR PHARMACEUTICS (2018)
RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models
Oi Kwan Wong et al.
Oncotarget (2018)
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial
Vidyalakshmi Chandramohan et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer
Nathan Simon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer
Nathan Simon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
Xiaojun Liu et al.
CANCER RESEARCH (2015)
Systemic toxic effects induced by the aqueous extract of the fire coral Millepora complanata and partial purification of thermostable neurotoxins with lethal effects in mice
Alejandro Garcia-Arredondo et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2015)
Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities
Judith Niesen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Advances in Anticancer Immunotoxin Therapy
Christine Alewine et al.
ONCOLOGIST (2015)
In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
Kevin Hollevoet et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Targeted Cytolysins Synergistically Potentiate Cytoplasmic Delivery of Gelonin Immunotoxin
Christopher M. Pirie et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity
Yu Cao et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Structures of Adnectin/Protein Complexes Reveal an Expanded Binding Footprint
Vidhyashankar Ramamurthy et al.
STRUCTURE (2012)
The ERBB network: at last, cancer therapy meets systems biology
Yosef Yarden et al.
NATURE REVIEWS CANCER (2012)
A novel hybrid peptide targeting EGFR-expressing cancers
Masayuki Kohno et al.
EUROPEAN JOURNAL OF CANCER (2011)
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
Stuart L. Emanuel et al.
MABS (2011)
Inhibition of TNF-α produced by Kupffer cells protects against the nonspecific liver toxicity of immunotoxin anti-Tac(Fv)-PE38, LMB-2
M Onda et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
